[{"data":1,"prerenderedAt":58},["ShallowReactive",2],{"pipeline-results":3},[4,15,22,28,32,37,40,43,48,52],{"molecule-name":5,"indication":6,"therapeutic-area":7,"expand":8,"description":9,"additional-info":9,"prescribing-info-link":10,"progress":11,"phase":12,"color":13,"trial":14},"nuvisertib (TP-3654)","Myelofibrosis","Oncology","","Donec sed odio dui. Praesent commodo cursus magna, vel scelerisque nisl consectetur et.","https:\u002F\u002Fwww.google.com","45","1\u002F2","green","https:\u002F\u002Fclinicaltrials.gov\u002Fstudy\u002FNCT04176198",{"molecule-name":16,"indication":17,"therapeutic-area":7,"expand":8,"description":18,"additional-info":8,"prescribing-info-link":8,"progress":19,"phase":20,"color":13,"trial":21},"enzomenib (DSP-5336)","Acute leukemia","test111","60","2","https:\u002F\u002Fclinicaltrials.gov\u002Fstudy\u002FNCT04988555",{"molecule-name":23,"indication":24,"therapeutic-area":7,"expand":8,"description":9,"additional-info":9,"prescribing-info-link":10,"progress":25,"phase":26,"color":13,"trial":27},"DSP-0390","Glioblastoma","30","1","https:\u002F\u002Fclinicaltrials.gov\u002Fstudy\u002FNCT05023551",{"molecule-name":29,"indication":30,"therapeutic-area":7,"expand":8,"description":9,"additional-info":9,"prescribing-info-link":10,"progress":11,"phase":12,"color":13,"trial":31},"SMP-3124","Solid tumors","https:\u002F\u002Fclinicaltrials.gov\u002Fstudy\u002FNCT06526819",{"molecule-name":33,"indication":34,"therapeutic-area":35,"expand":8,"description":9,"additional-info":9,"prescribing-info-link":10,"progress":25,"phase":26,"color":36,"trial":8},"DSP-0551","Tremor associated with Parkinson’s disease","CNS","green-olive",{"molecule-name":38,"indication":39,"therapeutic-area":35,"expand":8,"description":18,"additional-info":8,"prescribing-info-link":8,"progress":25,"phase":26,"color":36,"trial":8},"DSP-2342","To be determined",{"molecule-name":41,"indication":42,"therapeutic-area":35,"expand":8,"description":9,"additional-info":9,"prescribing-info-link":10,"progress":11,"phase":12,"color":36,"trial":8},"DSP-0378","Progressive Myoclonic Epilepsy, Developmental Epileptic Encephalopathy",{"molecule-name":44,"indication":45,"therapeutic-area":46,"expand":8,"description":18,"additional-info":8,"prescribing-info-link":8,"progress":11,"phase":12,"color":36,"trial":47},"DSP-1083","Parkinson’s disease","CNS, Regenerative Medicine","https:\u002F\u002Fclinicaltrials.gov\u002Fstudy\u002FNCT06753331",{"molecule-name":49,"indication":50,"therapeutic-area":46,"expand":8,"description":9,"additional-info":9,"prescribing-info-link":10,"progress":11,"phase":12,"color":36,"trial":51},"DSP-3077","Retinitis Pigmentosa","https:\u002F\u002Fclinicaltrials.gov\u002Fstudy\u002FNCT06891885",{"molecule-name":53,"indication":54,"therapeutic-area":55,"expand":8,"description":9,"additional-info":9,"prescribing-info-link":10,"progress":25,"phase":26,"color":56,"trial":57},"fH1\u002FDSP-0546LP","Influenza virus prophylaxis","Other","silver","https:\u002F\u002Fclinicaltrials.gov\u002Fstudy\u002FNCT06460064",1786713712850]